Lorence Kim
Fortune : 12 M $ au 31/05/2026
Fortune : 12 M $ au 31/05/2026
Lorence H.
Kim is the founder of Ascenta Capital Management LLC, founded in 2023, where the title held is Managing Partner.
Current jobs include Independent Director at Cencora, Inc. since 2022; Independent Director at Revolution Medicines, Inc. since 2022; Director at ADARx Pharmaceuticals, Inc. since 2023; Director at Flare Therapeutics, Inc.; Director at Abata Therapeutics, Inc. since 2021; Trustee at Prep for Prep; Member-Governors Board at American Red Cross, Inc.; and Chief Financial Officer at ModernaTX, Inc. since 2014.
Former jobs include Managing Director at Goldman Sachs & Co. LLC from 1999 to 2014; Director at Odyssey Therapeutics, Inc.; Independent Director at Cowen, Inc. from 2022 to 2023; Independent Director at Seres Therapeutics, Inc. from 2014 to 2020; Venture Partner at Third Rock Ventures LLC from 2020 to 2022; and Chief Financial Officer at Moderna, Inc. from 2014 to 2020.
Education includes an undergraduate degree from Harvard University in 1995, an MBA from The Wharton School of the University of Pennsylvania in 2000, and a doctorate from the University of Pennsylvania Medical Center in 2000.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 69 948 ( 0,03 % ) | 11 M $ | 31/05/2026 | |
| 05/03/2026 | 4 081 ( 0 % ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Directeur/Membre du Conseil | 12/07/2022 |
| CENCORA, INC. | Directeur/Membre du Conseil | 01/10/2022 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Directeur Financier/CFO | - |
American Red Cross, Inc.
American Red Cross, Inc. Services to the Health IndustryHealth Services Provides individual and family social services | Directeur/Membre du Conseil | - |
Ascenta Capital
Ascenta Capital Investment ManagersFinance Ascenta Capital is an active manager. | Fondateur | 01/01/2023 |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Directeur/Membre du Conseil | 20/01/2023 |
Prep for Prep
Prep for Prep Miscellaneous Commercial ServicesCommercial Services Engages in leadership development program activities | Directeur/Membre du Conseil | - |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Directeur/Membre du Conseil | - |
Abata Therapeutics, Inc.
Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Directeur/Membre du Conseil | 01/06/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░░░ ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 18 |
|---|---|
Cencora, Inc.
Cencora, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Prep for Prep
Prep for Prep Miscellaneous Commercial ServicesCommercial Services Engages in leadership development program activities | Commercial Services |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Finance |
American Red Cross, Inc.
American Red Cross, Inc. Services to the Health IndustryHealth Services Provides individual and family social services | Health Services |
Cowen, Inc.
Cowen, Inc. Investment Banks/BrokersFinance Provides corporate & investment banking and financial services | Finance |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
Seres Therapeutics, Inc.
Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania Medical Center
University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Medicines, Inc.
Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
Odyssey Therapeutics, Inc.
Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Health Technology |
Abata Therapeutics, Inc.
Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Health Technology |
Ascenta Capital
Ascenta Capital Investment ManagersFinance Ascenta Capital is an active manager. | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national